HISTOLOGIC FEATURES OF METASTATIC PROSTATE-CANCER

被引:18
作者
BRAWN, P
机构
[1] Olin E. Teague Veterans Administration Medical Center, Temple, TX
关键词
PROSTATE CARCINOMA; DEDIFFERENTIATION; METASTASES; STAGING LYMPHADENECTOMIES;
D O I
10.1016/0046-8177(92)90107-E
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Prostate carcinomas begin as well-differentiated lesions. Before metastases occur these carcinomas dedifferentiate into moderately or poorly differentiated lesions and increase in size to at least 1 cm3. Well-differentiated lesions rarely metastasize and metastases are rarely well differentiated. Positive staging lymphadenectomies usually contain moderately differentiated metastases. Patients with moderately differentiated metastases have a statistically significant better survival than patients with poorly differentiated metastases. Metastases typically disseminate as they dedifferentiate, with stage D1 metastases being moderately differentiated and stage D2 metastases being poorly differentiated. "Prostate-specific" immunohis-tochemical techniques and serum prostate-specific antigen levels may be helpful in determining whether a particular metastases is from the prostate. However, metastases of uncertain origin should rarely, if ever, be attributed to the prostate without confirmation that the patient has a prostate carcinoma with histologic features capable of metastasizing. © 1992.
引用
收藏
页码:267 / 272
页数:6
相关论文
共 46 条
[1]   PROSTATIC ADENOCARCINOMA - RELATIONSHIP OF GRADE AND LOCAL EXTENT TO PATTERN OF METASTASES [J].
BARZELL, W ;
BEAN, MA ;
HILARIS, BS ;
WHITMORE, WF .
JOURNAL OF UROLOGY, 1977, 118 (02) :278-282
[2]  
BRAWN P, 1990, CANCER-AM CANCER SOC, V65, P538, DOI 10.1002/1097-0142(19900201)65:3<538::AID-CNCR2820650326>3.0.CO
[3]  
2-G
[4]  
BRAWN PN, 1982, CANCER, V49, P525, DOI 10.1002/1097-0142(19820201)49:3<525::AID-CNCR2820490321>3.0.CO
[5]  
2-M
[6]   THE DEDIFFERENTIATION OF METASTATIC PROSTATE CARCINOMA [J].
BRAWN, PN ;
SPEIGHTS, VO .
BRITISH JOURNAL OF CANCER, 1989, 59 (01) :85-88
[7]  
BRAWN PN, 1991, CANCER, V68, P1592, DOI 10.1002/1097-0142(19911001)68:7<1592::AID-CNCR2820680721>3.0.CO
[8]  
2-M
[9]  
BRAWN PN, 1987, VIRCHOWS ARCH A, V441, P399
[10]  
BRAWN PN, 1983, CANCER, V52, P236